A Study of LY3314814 in Healthy Participants

Trial Identifier: 15993
Sponsor: AstraZeneca
Collaborator:
Eli Lilly and Company
NCTID:: NCT03222427
Start Date: January 2018
Primary Completion Date: February 2018
Study Completion Date: February 2018
Condition: Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
United Kingdom, West Yorkshire Leeds, West Yorkshire, United Kingdom